Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry-Reference-Cited by-同舟云学术

Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry

Published:2022-12-25 Issue:5 Volume:83 Page:454-461
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Wei Jun¹,Beebe‐Dimmer Jennifer²,Shi Zhuqing¹,Sample Christopher³,Yan Guifang⁴,Rifkin Andrew S.¹,Sadeghpour Azita³,Gielzak Marta⁴,Choi Sodam⁴,Moon David³,Zheng S. Lilly¹,Helfand Brian T.¹⁵,Walsh Patrick C.⁴,Xu Jianfeng¹^ORCID,Cooney Kathleen A.³,Isaacs William B.⁴

Affiliation:

1. Program for Personalized Cancer Care NorthShore University Health System Evanston Illinois USA

2. Barabara Ann Karmanos Cancer Institute Wayne State University School of Medicine Detroit Michigan USA

3. Department of Medicine Duke University School of Medicine and Duke Cancer Institute Durham North Carolina USA

4. Department of Urology, The Brady Urological Institute The Johns Hopkins School of Medicine Baltimore Maryland USA

5. Department of Surgery University of Chicago Pritzker School of Medicine Chicago Illinois USA

Funder

U.S. Department of Defense

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24477

Reference47 articles.

1. National Cancer Institute. Cancer stat facts: prostate cancer.2022. Accessed Feb 28 2022.https://seer.cancer.gov/statfacts/html/prost.html

2. Cancer statistics, 2022

3. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries

4. Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies

5. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline Mutations and Ancestry in Prostate Cancer;Current Oncology Reports;2024-01-24